Articles

1-20 of 2181 < first | prev | | last >
  • Purple Rain and Opioid Awareness

    The FDA has taken several actions to help reduce the number of people who become addicted, or who ultimately overdose from prescription opioids

    02/25/2017
  • Next-Generation Analytics: Actionable Insights on Tap

    On-demand access to the latest business intelligence is the key to almost every strategic priority life sciences organizations are working towards. But it can’t be delivered without the right groundwork.

    Elvis Paćelat, VP of Compliance Management, AMPLEXOR
    02/23/2017
  • No Easy Answers for Drug Pricing

    Improving manufacturing efficiencies offers most concrete possibilities for cost reduction

    Jerry Martin, pharmaceutical and life sciences consultant, PMMI
    02/21/2017
  • The Evolving Biopharma Contract-Manufacturing Market

    Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing

    Andrea Gennari, Martin Loesch, Alberto Santagostino and Ralf Otto, McKinsey & Co.
    01/31/2017
  • Inking the Deal

    Mastering the art of lasting outsourcing relationships in the pharmaceutical industry

    Karen Langhauser, Chief Content Director
    01/31/2017
  • FDA Gathers Faster Drug Data

    FDA implements initiatives to speed drug approvals, labeling changes and delivery

    Katie Weiler, Managing Editor
    01/30/2017
  • The Art of the Request for Proposals

    A well-written RFP and effectively managed process is well worth the upfront time and effort

    Ron Herman, Senior Partner, NexGen Consulting Group, LLC
    01/23/2017
  • GDUFA, Take II

    GDUFA’s second iteration emerges from backlogs and negotiations, promising speed, clarity and transparency

    Karen Langhauser, Chief Content Director
    12/12/2016
  • 5 Strategies for Generic Supply Chains

    What leading companies are doing to drive holistic improvements across their complex supply chains

    Andrew Gonce, Xin Huang, Jordan Levine and Martin Lösch, McKinsey & Company
    12/12/2016
  • The Digital Game-Changer

    For pharma operations, the question isn’t “When to go digital?” It’s “How fast can we get there?”

    Dr. Marcus Ehrhardt, Partner, PWC’S STRATEGY&
    12/09/2016
  • The Rise of Biosimilars

    North America and Europe will dominate the global biosimilars market as demand rises for these products

    Nigel Walker, Managing Director, That’s Nice / Nice Insight
    12/09/2016
1-20 of 2181 < first | prev | | last >